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It is generally important to elucidate airway epithelial cell lin-
eages and to identify multipotent progenitors as targets for
 
gene therapy. Stem (S) cells are typically present in specialized
compartments spatially proximal to their differentiated prog-
eny, but an equivalent paradigm has not been demonstrated
in the airway. We discovered a distinct population of cells dis-
playing high levels of keratin expression in murine tracheal
submucosal gland ducts, and tested the hypothesis that bro-
modeoxyuridine (BrdU) label–retaining cells (LRCs), thought
to represent the S-cells, were present in this compartment.






 inhalation for 4 wk and received intraperito-
neal injections of BrdU every 48 h during the injury and repair
period. At 3 and 6 d after injury, BrdU-positive epithelial cells
were noted along the entire tracheal length in both basal and
lumenal cell positions. At later time points (20 and 95 d) LRCs
were localized to gland ducts in the upper trachea and to sys-
tematically arrayed foci in the lower trachea, typically near the
 
cartilage–intercartilage junction. LRCs were not pulmonary
neuroendocrine cells. Heterotopic tracheal grafts after surface
epithelial removal demonstrated reconstitution of a surface-
like epithelium from gland remnants. These results suggest
that airway epithelial S cells are localized to specific niches.
 
Airway diseases such as asthma, chronic bronchitis, and
cystic fibrosis are characterized by bronchial epithelial hy-
perplasia and metaplasia that likely contribute to the down-
ward spiral of physiologic impairment. Elucidation of epi-
thelial cell lineage is fundamental toward understanding
mechanisms that alter epithelial phenotype. It is also im-
portant to identify cells with extensive progenitorial ca-
pacity as potential targets for gene therapy. Despite many
studies directed at understanding the growth properties of
specific subsets of cells constituting the pseudostratified
airway epithelium, a definitive model establishing progeni-
tor–progeny relationships in the normal steady state or in
response to injury has not yet been established (1).
Stem (S)-cell theory divides epithelial cell types in re-
newing tissues into three major compartments according
to proliferation capacity and differentiation potential (re-
cently reviewed in Refs. 2 and 3). S cells are pluripotent to
generate all cell types in the tissue compartment and usu-
ally have adequate growth capacity for the life of the ani-
mal. In general, S cells turn over slowly and display mini-
mal physiologic differentiation. As early descendents of S
cells, transiently amplifying (TA) cells retain significant
growth capacity while acquiring differentiated functions.
TA cells eventually become incapable of proliferation and
enter the terminally differentiated (TD) compartment. To
conserve growth potential and to prevent genetic injury
while vulnerable during mitosis, S cells are thought to cy-
cle slowly and are recruited only as demanded by tissue
turnover. Thus, much of the increase in cell number in the
steady state occurs in the TA population. One conse-










H]thymidine or BrdU labeling will mark S cells that re-
tain the label for an extended period due to slow turnover.
Thus, an adequate labeling intensity and a suitable wash-
out period of the TA and TD compartments will result in
so-called label-retaining cells (LRCs) thought to represent
the S-cell compartment.
In extensively studied tissues such as the epidermis, in-
testinal epithelium, and cornea, label-retaining S cells re-
side in specialized and generally well protected niches spa-
tially proximal to their more differentiated TA and TD
progeny. However, S-cell niches have not been demon-
strated in the psuedostratified airway epithelium.
In studies aiming to isolate specific subpopulations of
murine tracheal epithelial cells, we discovered a distinct
population of cells displaying high levels of keratin gene
and protein expression in submucosal gland ducts. Intrigu-
ingly, high keratin protein content in a subset of corneal
epithelial cells (4) ultimately led to the discovery that
LRCs of the cornea reside in the limbus (5). Further, ex-
pression of a specific keratin has been reported to be a
marker for hair-follicle S cells (6). To determine whether
the keratin-rich cells in the murine trachea were LRCs,
we performed long-term BrdU labeling and washout stud-
ies of purposefully injured murine tracheas. Injury was
required to stimulate cell division in the normally quies-
cent tracheal epithelium. Pulmonary neuroendocrine cells
(PNECs) were localized to assess their role in S-cell pat-
terning. Heterotopic tracheal grafts denuded of their sur-
face epithelium were used to determine whether gland and







All animals were handled under Institutional Animal Care and















 This report has been reviewed by the National Health
and Environmental Effects Research Laboratory, U.S. Environmental
Protection Agency, and approved for publication. Approval does not sig-
nify that the contents necessarily reflect the views and policies of the
agency, nor does mention of trade names and commercial products consti-
tute endorsement or recommendation for use.
 
Address correspondence to: 
 
Scott H. Randell, Ph.D., UNC CF Center, CB
 











gal; bromodeoxyuridine, BrdU; calcitonin













immunoglobulin, Ig; label-retaining cell, LRC; pulmonary neuroendo-
crine cell, PNEC; parts per million, ppm; stem, S; transiently amplifying,
TA; terminally differentiated, TD.
 
 




: Airway Epithelial Stem Cells 663
 
mouse strain in which 6,000 base pairs (bp) of the basal cell–spe-
cific human keratin 5 promoter drives expression of the bacterial
LacZ gene (7, 8) was a kind gift from Dr. Elaine Fuchs (Univer-









excised tissues was detected using X-gal substrate as previously
described (9). Whole-mount images were obtained and tissues
were processed for paraffin embedding. Sections were counter-
stained with nuclear fast red.
 












) binding sites in
mouse trachea were detected using biotinylated lectin as previ-
ously described (10). Polyclonal antibodies against the mouse ho-
mologues of human cytokeratin 14 and 18 were generated by
immunizing rabbits with peptides CGKVVSTHEQVLRTKN-
COOH and CGRVVSETNDTRVLRH-COOH, respectively, con-
jugated to maleimide-activated ovalbumin or bovine serum albu-
min (Pierce, Rockford, IL). Antibodies were affinity-purified on
peptide linked to maleimide-activated Sepharose (Pierce). Im-
munostaining was performed on formalin-fixed paraffin sections
using Texas Red–labeled antirabbit antibody (Jackson Immu-
noresearch, West Grove, PA) and confocal microscopy.
 




Because the normal rodent tracheobronchial epithelium is mitot-









H]thymidine or BrdU (11, 12), it is necessary to recruit S
cells into the actively dividing pool to possibly visualize LRCs.
Two methods of tracheal epithelial damage were used: intratra-
cheal instillation of polidocanol (Sigma, St. Louis, MO), a deter-
gent clinically used as a sclerosing agent and to facilitate gene




 inhalation, a well-studied model





l of 2% polidocanol in phosphate-buffered saline (PBS)
was directly instilled into the trachea just below the pharynx in
anesthetized (intraperitoneal ketamine/xylazine mixture) CD1
mice (4- to 6-wk-old males; Charles River, Raleigh, NC). To assess
the damage qualitatively, three animals were killed by barbiturate
overdose at 10 min or 2 or 24 h after instillation and their tracheas
were removed for conventional histology. Nine mice were ex-





 for 3 h in monitored chambers at the U.S. Environmental
Protection Agency facility in Research Triangle Park, NC, and
tracheal epithelial damage was assessed histologically at 2 or 24 h.
 
Repeated Damage and BrdU Labeling
 




 25 g) received weekly tracheal dam-









tion (four escalating doses: 500 ppm for 3, 3.5, 4, or 4.5 h) as de-
scribed earlier. In addition, the mice received intraperitoneal
injections of BrdU (2 mg) every 48 h beginning 2 h after the first














and their tracheas were examined for BrdU incorporation by im-
munohistochemistry as described later. Controls included groups
of mice receiving BrdU but without tracheal damage, and dam-




BrdU incorporation was detected in sections of trachea and in-
testine using a staining procedure modified from previously re-
ported methods (16). Fixation with Omnifix (FR Chemical, Mt.
Vernon, NY) resulted in much stronger staining than with forma-
lin and we also avoided antimouse immunoglobulin (Ig) G sec-
ondary antibodies to prevent high background. We used a fluo-
rescein isothiocyanate (FITC)–labeled anti-BrdU monoclonal
antibody (Caltag, Burlingame, CA) followed by rabbit anti-FITC
IgG (Molecular Probes, Eugene, OR) which was detected with
peroxidase-conjugated goat antirabbit IgG (Jackson Immunore-
search). Optimal antibody dilutions were determined empirically.
A duplicate section was included on each slide in which an equal
concentration of nonspecific FITC-labeled mouse IgG1 replaced
the primary antibody. A positive control slide of a BrdU pulse–
labeled (2 h) mouse intestine was included in every staining ses-
sion. This staining method was very sensitive, resulting in uni-
form, densely stained nuclei in crypt enterocytes after 2-h pulse
labeling. As well as densely stained cells, we also observed fainter
and heterogeneously labeled nuclei (small “dots” within the nu-
clei instead of uniformly brown nuclei) in the tracheas of animals
chronically exposed to BrdU, possibly daughter cells in which
BrdU was diluted.
 
Measurement of BrdU Labeling
 
Approximately 600 cells from three different regions (200/region)
of every longitudinally sectioned trachea were examined for cell
type and BrdU incorporation. The mouse trachea contains ap-
proximately 14 cartilage rings and, in the CD1 strain, tracheal
glands are typically present only within the uppermost four rings
(17). Region 1 began just above the most cephalad cartilage ring,
with regions 2 and 3 beginning at rings 5 and 9 distal to the phar-
ynx, respectively. A total of 100 consecutive cells beginning at
each level on both sides of the trachea were scored. Staining was
considered positive if the signal was nuclear and clearly above
that detected as background on the adjacent negative control sec-
tion, including faintly and heterogeneously stained nuclei. Cells
were categorized as basal if they were small, cuboidal to squam-
oid in shape, and closely adherent to the basal lamina, and the
nucleus was in the bottom third of the epithelial layer. All other
cells were categorized as columnar. Several other studies have
discriminated between specific cell types, but these investigations





midine autoradiography on thin plastic or epoxy sections. Using
Omnifix and paraffin embedding, and after acid and trypsin
treatment needed for BrdU localization, we were confident dis-
criminating only between basal and columnar cells. Areas of ob-
vious artifact due to tissue processing were excluded. We noted
densely stained BrdU-positive nuclei in the tracheas of mice
chronically labeled with BrdU. Because these cells are of particu-





PNECs are proposed to play important roles in pulmonary devel-
opment and epithelial cell growth (18–22). We immunostained
for calcitonin gene–related peptide (CGRP) to localize PNECs in




Schedule for airway injury,
BrdU injections, and tissue analysis
 
Day 0 7 14 21 22
































2 mg of BrdU was administered intraperitoneally every 48 h beginning 24 h
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We studied heterotopic tracheal grafts to examine whether tra-
cheal gland duct and/or acinar remnants could reconstitute a sur-
face-like epithelium in denuded tracheas. Tracheas were re-
moved from donor CD1 mice and the surface cells were removed




C in 0.1% Protease XIV (Sigma) in
F-12 medium on a tilting platform. Histologic analysis demon-
strated complete removal of the surface epithelium (illustrated in
Figure 6). After surface denudation, Protease XIV action was
terminated by addition of fetal bovine serum to 10% and the
grafts were washed with three changes of F-12 medium. The pha-
ryngeal opening and the trachea distal to ring 5 were closed with
ligating clips. The upper, gland-containing tracheal portion was
transplanted to the subcutaneous space of Nu/Nu mice and al-





Detection of a Keratin-Rich Compartment in the Murine 
Tracheal Epithelium
 
In initial studies directed toward isolation of specific air-




gal activity in the
trachea of transgenic mice in which 6,000 bp of the basal
cell–specific human keratin 5 promoter drives expression





pattern faithful to endogenous expression in several or-
gans examined but with some notable exceptions (7), and
high-level activity appears to correlate with growth poten-





ity was visible only in a circumferential band in the upper
trachea, with a few small patches along a descending pos-
terior stripe (Figures 1A, 1C, and 1D), a pattern most con-
sistent with the localization of tracheal glands. No blue
cells were visible in the lower trachea. Cross sections re-
vealed scattered positive basal cells in the upper tracheal
surface epithelium, prominently stained small groups of
cells in the ducts of submucosal glands, and positive gland
myoepithelial cells (Figure 1E). This was not due to an ab-
sence of tracheal basal cells, which were clearly visible at










correlated with high-level keratin protein expression as
detected with antibodies against mouse keratins 14 and 18.
Keratin 14 is usually coexpressed with keratin 5 (23, 24)
and is present in surface basal cells and gland myoepithe-
Figure 1. High levels of keratin 5 promoter
activity in tracheal gland duct cells. Whole-
mount photographs of gal-stained tracheas
from heterozygous K5gal6000 mice (A,
C, and D) or negative control littermates
(B) and a histologic section through a pos-
itive trachea at the level of a gland duct
opening (E). Squamous epithelial cells along
the pharyngeal floor are positive (upper-
most blue cells in A), as are cells in and
around tracheal glands. Groups of faintly
positive cells are visible in a descending
posterior stripe (circled in C and D). (E)
Scattered surface basal cells (solid arrow),
gland duct cells (arrowheads), and gland
myoepithelial cells (open arrows) are stained.
Original magnifications: A and B, 8; C
and D, 64; E, 400.
Figure 2. Keratin-rich cells in tracheal gland ducts. GSIB4 lectin
(A), keratin 14 (B), keratin 18 (C), and rabbit IgG control (D)
staining of mouse upper trachea. The surface epithelium has a
continuous lining of basal cells that extend into the gland duct
(arrows in A). Clusters of cells in the gland duct and surrounding
surface epithelium as well as gland myoepithelial cells are keratin
14–positive (arrows and arrowheads in B, respectively). Gland
duct cells, surface epithelial cells, and columnar acinar cells are
keratin 18–positive (arrows, arrowheads, and asterisk in C, re-
spectively). Original magnification in all panels: 400.
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lial cells. Keratin 18 is present in suprabasal, columnar sur-
face cells and gland acinar cells. Interestingly, basal cells in
gland ducts were positive for both keratins. These studies
demonstrate the presence of a compartment of cells likely
demonstrating very high keratin 5 promoter activity rela-
tive to other airway cell types. These cells abundantly con-
tain both basal and nonbasal cell type–specific keratin pro-
teins. This result is intriguing in that relatively high keratin
content has been viewed as a biochemically primitive phe-
notype (4) and this observation led to formal demonstra-
tion that corneal epithelial S cells reside in the limbus (5).
 
Damage Models to Enable Localization of LRCs in the 
Murine Tracheal Epithelium
 





will mark epithelial S cells which, by virtue of their slow
cycle time, will retain the label for an extended period.
Rapidly renewing systems such as the epidermis (25–27)
are amenable to localization of LRCs without additional
recruitment of S cells, as was necessary for the cornea
(5). Because the basal rate of mitosis in healthy airways is
 
exceedingly low (11) it was necessary to injure the epi-
thelium to cause cell proliferation. Two types of injury





 inhalation. As shown in Figure 3, the




l of 2% polidocanol in PBS
caused widespread removal of the epithelium. At first the
superficial columnar layer was lost, and by 24 h patches of
either epithelial remnants or denuded basal lamina were
visible. Heterogeneity was possibly due to mechanical
damage by the cannula during instillation and/or inhomoge-
neous physical dispersion of the detergent solution. At 2 h




, the superficial columnar
epithelial cells uniformly displayed cytopathic changes
indicative of degeneration. Gland acini appeared rela-
tively empty and gland ducts were dilated with mucin. At
24 h, the basal cell layer was largely retained. In both cases,
eosinophilic material constituting a hyaline membrane
was frequently observed. Within 3 d after both injuries,
repair was well underway and a columnar layer was present
but the percentage of the epithelial surface covered by
cilia was still depressed. By 7 d, a normal-appearing epi-
Figure 3. Characterization of tracheal epithelial injuries and the subacute proliferative response. Histologic sections of upper (A–C and
G–I) or lower (D–F ) trachea from control (A, D, and G), polidocanol-treated (B, E, and H), or SO2-exposed (C, F, and I) mice at 2 (A–
C) or 24 h (D–I) after treatment. At 2 h after both injuries, cells closely adherent to the basal lamina persisted; eosinophilic material
covered the epithelial surface 2 h after SO2 (arrows in C). By 24 h in polidocanol animals, there were patches of denuded basal lamina
with an eosinophilic covering (arrows in E). However, 24 h after SO2, a uniform epithelial monolayer was present (F). A 1-h pulse label
of BrdU revealed a 1.3% labeling index in untreated controls (G) but very high labeling of remaining epithelial cells 24 h after poli-
docanol (H) or SO2 (I). A–F: hematoxylin and eosin stain, original magnification 200; G–I: BrdU immunostaining, original magnifica-
tion 400.
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thelium was re-established. Cell proliferation was assessed
with a 1-h pulse label of BrdU 24 h after injury. Nuclear
staining was negligible in isotype-matched antibody con-
trols or in animals not receiving BrdU. An average tracheal
BrdU labeling index of 1.3  0.3% (mean  standard er-
ror of the mean [SEM], n  3) was obtained from normal
untreated animals. At 24 h after both injuries, the BrdU
labeling index of viable surface epithelial cells was greater
than 50%.
Identification of LRCs in Repetitively Injured Tracheas 
Chronically Labeled with BrdU
Mouse tracheas were injured with polidocanol or SO2
once per week for 4 wk and the mice received BrdU injec-
tions every other day from the day of the first injury to 1 d
after the last injury. There were no treatment-related
mouse deaths in our studies, and groups of mice were
killed at 3, 6, 21, and 95 d after the final injury. Trachea
and duodenum were processed for BrdU immunostaining.
Representative photomicrographs and morphometry re-
sults are shown in Figures 4 and 5, respectively. At the 3-d
time point, BrdU-positive duodenal enterocytes were lo-
calized to the lower half and middle of the villus, whereas
by 6 d only scattered positive cells were present at the vil-
lus tip, consistent with the known cell migration pattern in
the crypt–villus unit (not shown). BrdU-positive entero-
cytes were no longer detectable at 21 and 95 d. Positive nu-
clei were absent in animals that were injured but did not
receive BrdU.
Figure 4. BrdU LRCs localize to upper tracheal gland ducts and
to systematically arrayed foci in the lower trachea. Panels A–D
are sections of upper trachea from mice 3, 6, 22, or 95 d, respec-
tively, after repeated SO2 injury and BrdU administration. Panel
E is from a polidocanol-treated mouse at 95 d. Densely stained
LRCs are clearly visible in gland ducts (arrows in D and E). Pan-
els F–J are from the distal trachea. Panels F and G demonstrate a
high labeling index in both basal and columnar cells 3 d after SO2
or polidocanol, respectively. Panel H shows two foci of epithelial
LRCs in the distal trachea 95 d after polidocanol treatment (ar-
rows). Panels I and J are low- and high-power views, respectively,
of distal trachea 95 d after SO2 treatment. Epithelial LRC clus-
ters are systematically arrayed and tend to correspond to the lo-
cation of the cartilage–intercartilage junction (arrows). All pan-
els were immunostained for BrdU. Original magnifications: A–H
and J, 400; I, 100.
Figure 5. BrdU labeling index and locations of LRCs. (A) The
mean tracheal surface epithelial BrdU labeling index including
both faintly and strongly labeled cells. There was a very signifi-
cant overall time effect by analysis of variance (ANOVA) and P 
0.05 for all comparisons with the Day 3 groups (two-tailed t test).
(B) The ratio of BrdU-positive basal to columnar cells. There
was a significant time effect by ANOVA. In the SO2 group, Day
6 is significantly different than all other time points, whereas in
the polidocanol group Day 3 is significantly different than all
other time points (P  0.05, two-tailed t test). In A and B, values
from the upper, middle, and lower trachea were not different and
were averaged. (C–F) The locations of strongly labeled cells in
the upper and lower trachea 95 d after SO2 or polidocanol treat-
ment expressed as percentages of the total strongly labeled cells.
P values for the comparison with gland duct in C and D, and co-
lumnar versus basal in E and F, are given in parentheses (two-
tailed t test). Four or five animals were studied per time point.
Values are means  SEM.
 
Borthwick, Shahbazian, Krantz, et al.: Airway Epithelial Stem Cells 667
Staining results in tracheas repetitively injured with
polidocanol or SO2 and chronically labeled with BrdU
were similar. At 3 d after the final injury (31 and 34 d after
the first BrdU injections, respectively), the surface epithe-
lial BrdU labeling index was approximately 65%. BrdU-
positive epithelial cells were noted in both luminal and basal
positions along the surface of the entire trachea. In the tra-
cheal gland system, duct, acinar, and myoepithelial cells
were labeled. A heterogeneous pattern of nuclear BrdU
staining was observed in both the surface epithelium and
in glands. Many cells had focally positive “dots” within the
nucleus and faint background staining of nuclear matrix,
whereas other cells had more uniformly densely stained
nuclei. Presumably, the fainter staining was due to dilution
of the BrdU label, which occurred as cells proliferated in
the absence of BrdU. Even at 3 and 6 d, densely stained
cells were preferentially localized to gland ducts and in
scattered surface foci in both the upper and lower trachea.
By 21 and 95 d after the last injury the overall BrdU stain-
ing was much weaker, although numerous faintly stained
BrdU-positive cells were still visible. The labeling index,
including faintly stained cells, still exceeded 30%. Densely
stained cells were preferentially localized to submucosal
gland ducts in the upper trachea. Clusters of cells with
strong BrdU staining were also systematically distributed
along the surface epithelium in the glandless lower trachea
and tended to correspond to the position of the cartilage–
intercartilage junction. The ratio of basal to columnar LRCs
in the distal trachea was approximately 2 to 1.
LRCs Are Not PNECs
PNECs are proposed to play important roles in lung devel-
opment and as regulators of epithelial cell growth. The
unique distribution of LRCs suggested a possible associa-
tion with PNECs, and we used CGRP staining to assess the
relationship. As illustrated in Figures 6A and 6B, gland
duct openings in the upper trachea were innervated with
CGRP-positive fibers but PNECs were rare in this loca-
tion. Because several LRCs were visible in each section
from Day 95 animals containing gland ducts, it is clear that
upper tracheal LRCs were not CGRP-positive PNECs. In
the lower trachea, PNECs were frequently located near the
cartilage–intercartilage junction where gland rudiments
were occasionally found and where foci of LRCs were typ-
ically present. However, there were many more LRCs than
PNECs. Thus, in the lower trachea, PNECs were systemat-
ically distributed along with LRCs, which may reflect their
contribution to an airway trophic unit.
Gland and Gland Duct Remnants Can Regenerate a 
Surface-like Epithelium
Heterotopic tracheal grafts were used to test the hypothe-
sis that gland and/or gland duct cells could contribute to
surface epithelial regeneration. In this experiment, tra-
cheas were harvested and the surface epithelium removed
by exposure to protease. No remaining surface epithelial
cells were seen in eight of eight protease-treated tracheas
when viewed histologically (Figure 6C). Gland duct and
acinar cells were present but were apparently “loosened”
from the basal lamina by the protease. During the early
stages after transplantation into Nu/Nu mice the glands re-
gressed, but by 28 d they had increased in size. Also at 28 d,
cystic spaces lined by a cuboidal epithelium containing cil-
iated cells appeared. Because of a lack of specific markers
for gland ducts, it is impossible to determine whether this
was a dilated gland duct structure or a new surface epithe-
lium. However, the cells resembled the low cuboidal epi-
thelium typically present in mouse bronchi. Although not
conclusive, this experiment supports the idea that gland or
gland duct cells can reconstitute a surface-like epithelium.
Are Airway Epithelial Stem Cells Present in Distinct 
Morphologic Compartments?
There has been a long-standing debate regarding the iden-
tity of airway epithelial S cells. Several studies suggest that
basal cells are progenitors (28–32), but a strong prolifera-
tive response in secretory cells following injury (33), the
late developmental appearance of basal cells (34–36), and
studies with isolated cell populations (37) make a case for
small-granule secretory cells or an undifferentiated colum-
nar cell. There is evidence for great plasticity in growth
and differentiation potential of airway epithelial cells (38)
and our earlier studies showing that both basal and non-
Figure 6. LRCs are not pulmonary neuroendocrine cells and
gland remnants regenerate a surface-like epithelium. (A and B)
Immunostaining for CGRP in upper and middle trachea, respec-
tively, 95 d after SO2 exposure. Positive nerve fibers are visible in
the lamina propria (arrows in A) but PNECs are not present in
the epithelium that is predicted to have several LRCs. A solitary
PNEC is visible in the surface epithelium (arrow in B) near a
small gland rudiment (Gl) at the cartilage–intercartilage junction.
Panel C is from a protease-treated trachea before transplantation
and shows complete removal of the surface epithelium (arrows)
and “loosening” of gland duct (open arrowheads) and acinar (ar-
rowheads) cells. Panel D shows small gland remnants 14 d after
transplantation. Low- and high-power views of tracheal grafts 28 d
after transplantation (E and F, respectively) show an increase in
gland size and the presence of cystic spaces lined by a ciliated ep-
ithelium resembling the bronchial surface (arrows in F). Original
magnification: A, B, and F, 400; C, 200; D and E, 100.
 
668 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL. 24 2001
basal cells could regenerate a complete mucociliary epi-
thelium in tracheal grafts support this notion (16, 39). How-
ever, detailed analysis of gland neogenesis in xenografts
suggests that only a subset of human airway basal cells are
pluripotent, at least to form glands (40). A critical factor in
this debate is the specificity of the assay for “stemness.”
Within the context of a three-compartment model of cell
lineages, DNA precursor LRCs have been considered syn-
onymous with S cells in several renewing tissues (5, 27, 41).
To our knowledge, the present studies are the first attempt
to localize LRCs in the respiratory tract. Because epithe-
lial proliferation in the normal airway is too slow for suffi-
cient S-cell labeling, we chose two different tolerable inju-
ries. These treatments may not have been ideal in that
both tended to selectively remove superficial cells. Loss of
columnar cells and re-establishment of barrier function by
basal cells appears to be a basic property of the pseudo-
stratified epithelium (42). Selective removal of columnar
cells may have obscured their potential contribution. Fur-
ther studies, such as mechanical injury in the rat that
cleanly denudes a portion of the epithelium, leaving both
columnar and basal cells in the remaining portion (43),
would be useful but this was not feasible in mice. Although
[3H]thymidine labeling and autoradiography on thin plas-
tic or epoxy sections would have enabled more accurate
identification and quantification of labeled cells, we ruled
out the use of isotope on the basis of expense, environ-
mental impact, and the availability of BrdU as an alterna-
tive. Further, we had to decide on the route, dose, and fre-
quency of BrdU administration. Preliminary experiments
(S.H.R.’s unpublished results) with slow-release pellets that
may have allowed for continuous labeling demonstrated
unacceptable toxicity, and suitable implantable minipumps
have only a 7-d duration. There was no adverse effect on
body weight with the selected regimen of 2 mg BrdU every
other day. Although this dose strongly labeled dividing cells
within 1 h, low BrdU plasma levels between injections
probably resulted in labeling of only a subset of prolifer-
ating cells. Despite technical limitations due to injury type
and incomplete cell labeling, we were nonetheless able to
demonstrate clearly the preferential localization of LRCs
to specific niches in the mouse trachea, namely, gland
ducts in the upper trachea and systematically arrayed foci
associated with the cartilage–intercartilage junction in the
lower trachea. Perhaps these niches are analogous to “S
cell clusters” present in the epidermis (44). Although these
observations do not rule out a degree of progenitorial ca-
pacity among various tracheal-cell populations, they are
most consistent with localization of airway epithelial S
cells to distinct morphologic compartments. It is important
to note that LRCs may be either slow-cycling S cells or re-
sidual TD cells. The latest time point that we studied was
95 d, which we thought was a good compromise between
the probable epithelial cell life span (which, to our knowl-
edge, is not precisely known for the various cells of the
mouse trachea) and loss of BrdU label. It is likely that high
levels of proliferation occurred in locations between clus-
ters of LRCs. Some of the LRCs we noted may have been
residual TD cells, but minimal labeling of ciliated cells (the
one airway epithelial cell type generally considered to
have limited proliferation capacity) suggests that many of
the LRCs were slowly cycling S cells. More studies are
necessary to define tracheal cell life spans, to precisely
map LRCs in three dimensions, and to illustrate patterns
of cell proliferation and migration in relation to putative S
cell niches.
A “Zonal Model” for Airway Epithelial Stem Cells
One may envision the respiratory tract as comprised of
distinct “zones” with different cell lineage systems. Epi-
thelial cell composition and zone boundaries depend on
both the species and the individual animal history. In nor-
mal mice, a renewing cell system encompassing a gland-
containing, pseudostratified epithelium with Clara cells and
few goblet cells is present in the upper trachea. In rats, a
similar system, but with more goblet cells and no Clara
cells, is present in the entire trachea; whereas in humans
this zone penetrates many bronchial generations. Distally,
the airway epithelium becomes glandless, cuboidal, and
dominated by a Clara cell–based lineage system (45) be-
fore transitioning to a type II cell–based system (46) in the
alveoli. After injury or infection, cell composition and/or
positional boundaries may change. For example, glands
may form more distally, accompanied by goblet-cell meta-
plasia in small airways or bronchiolarized metaplasia of
the proximal alveolar region. Our results showing localiza-
tion of LRCs to upper tracheal gland ducts and to distinct
foci in the glandless distal trachea illustrate the presence
of related, but likely different, lineage systems in these dif-
ferent airway zones.
“Trophic Units” in the Airway Epithelium
Distal tracheal foci of LRCs tended to correspond with the
position of the cartilage–intercartilage junction where blood
vessels and nerves typically penetrate toward the epithe-
lial surface (47, 48), where gland rudiments were occasion-
ally observed (this study), and where single PNECs were
frequently present in the surface epithelium (this study).
Reciprocal epithelial–mesenchymal interactions involving
specific gene regulatory systems govern morphogenesis in
many organ systems (for recent review, see Ref. 49). Most
of the available data in lung focuses on developmental
branching morphogenesis (50), but recent studies impli-
cate the lymphoid enhancer factor 1 pathway as a regula-
tor of airway gland neogenesis (51). Mesenchymal, neural,
and epithelial elements within a defined structural frame-
work likely constitute a so-called “trophic unit” of the mam-
malian airway. There may also be a systematic relationship
between such units and respiratory tract field canceriza-
tion (52). It is interesting that a niche of LRCs was present
in tracheal submucosal gland ducts. We speculate that cells
in this location are strategically poised to serve as a reserve
in the event of cataclysmic injury—such as gastric acid as-
piration or smoke inhalation—and as a source of cells to
form, expand, and/or maintain submucosal glands. Al-
though the developmental derivation of airway glands from
the surface epithelium indicates a functional relationship,
it is also possible that their cell regeneration systems in the
adult are separate. In the latter case, the persistence of
LRCs within gland ducts may have been due to a lesser de-
gree of injury and slower cell turnover in the relatively
protected gland compartment. Lineage-mapping studies
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may help to resolve this issue. The relationship of LRCs in
gland ducts to oncocytes (53) or cystic fibrosis transmem-
brane conductance regulator–rich “flasklike cells” (54) re-
mains to be determined.
Conclusions
This report suggests the existence of S-cell niches in the
pseudostratified airway epithelium. Potential S-cell targets
for gene therapy likely reside within gland ducts and in
foci systematically arrayed along the surface of glandless
airways. Further studies are needed to discover unique
markers of airway epithelial S-cells, to better understand
the niche microenvironment, and to isolate and test puta-
tive airway epithelial S cells.
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